ArticleFrontiers in oncology2026

Efficacy and safety of PARP inhibitor maintenance therapy in elderly ovarian cancer patients: a real-world single-center retrospective cohort study.

Jingjing Lu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.